Research summary ·
Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis in the Gulf Cooperation Council: a modified Delphi approach.
Written based on 1 research study on PubMed, searched on 15 Nov 2026.
What was studied
This is a guideline written by experts in the Gulf countries. It covers HLH, a rare illness with extreme inflammation. HLH can be life-threatening. The guideline is meant for both children and adults. A panel of 15 experts from all Gulf countries took part. They read past studies and drew up 40 statements. Each expert then voted on how much they agreed with each one.
What they found
All 15 experts took part in the vote. All 40 statements reached agreement in round 1. The panel says checks for HLH should start once doctors suspect it. Scoring tools should help a doctor's own view, not replace it. Doctors should look for causes like infection, cancer, rheumatic disease or genes. Care should not wait in people with severe or worsening illness. Early gene tests are stressed for babies, young children and some families.
What it means for patients
The authors say the guideline gives Gulf doctors a shared way to handle HLH. It says doctors shape care to each person's age, illness and its cause. Doctors may weigh other drugs when HLH returns or does not respond. The same applies when people cannot cope with their first drugs. The guideline also says doctors send people early to certain centres. These centres have intensive care, advanced tests and transplant care.
Why it is not certain yet
This guideline rests on expert views and a review of past studies. The abstract does not give the strength of proof for each statement. The authors say more studies are needed in the Gulf region. These should look at how common HLH is there and its genes. They should also look at how people respond to care and how they do.
Source
Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis in the Gulf Cooperation Council: a modified Delphi approach.
PubMed · PMID 42807139We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Haemophagocytic lymphohistiocytosis publications